Biogened

Biogened is a Polish pharmaceutical and dermocosmetic company focused on the development, production, and distribution of specialized skincare solutions and medicinal products. The company is most recognized for its 'Dermedic' brand, which offers clinically tested products for sensitive, allergic, and problematic skin types, including treatments for acne and hair loss. Biogened maintains its own research and development facilities to formulate products based on dermatological research and innovative active ingredients. In addition to cosmetics, the firm manages a portfolio of generic pharmaceuticals and dietary supplements tailored for the Central and Eastern European markets. The company is publicly traded on the Warsaw Stock Exchange's NewConnect market.